Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001558370-24-015444
Filing Date
2024-11-13
Accepted
2024-11-13 08:34:46
Documents
71
Period of Report
2024-09-30

Document Format Files

Seq Description Document Type Size
1 10-Q mgtx-20240930x10q.htm   iXBRL 10-Q 2395117
2 EX-31.1 mgtx-20240930xex31d1.htm EX-31.1 11380
3 EX-31.2 mgtx-20240930xex31d2.htm EX-31.2 13959
4 EX-32.1 mgtx-20240930xex32d1.htm EX-32.1 6771
5 EX-32.2 mgtx-20240930xex32d2.htm EX-32.2 6779
  Complete submission text file 0001558370-24-015444.txt   9009122

Data Files

Seq Description Document Type Size
6 EX-101.SCH mgtx-20240930.xsd EX-101.SCH 60940
7 EX-101.CAL mgtx-20240930_cal.xml EX-101.CAL 53634
8 EX-101.DEF mgtx-20240930_def.xml EX-101.DEF 254042
9 EX-101.LAB mgtx-20240930_lab.xml EX-101.LAB 463342
10 EX-101.PRE mgtx-20240930_pre.xml EX-101.PRE 405829
74 EXTRACTED XBRL INSTANCE DOCUMENT mgtx-20240930x10q_htm.xml XML 1501449
Mailing Address 450 EAST 29TH STREET 14TH FLOOR NEW YORK NY 10016
Business Address 450 EAST 29TH STREET 14TH FLOOR NEW YORK NY 10016 646-860-7985
MeiraGTx Holdings plc (Filer) CIK: 0001735438 (see all company filings)

EIN.: 981448305 | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-38520 | Film No.: 241451342
SIC: 2836 Biological Products, (No Diagnostic Substances)
(CF Office: 03 Life Sciences)